Background: While illicit substances are commonly involved in the overdose crisis, prescription substances still play a role. Oftentimes, decedents do not have prescriptions for these substances at the time of death. As such, we sought to examine the prevalence of nonmedical drug use in Tennessee through linkage of fatal drug overdose and prescription data.
Methods: We used State Unintentional Drug Overdose Reporting System (SUDORS) data to identify fatal drug overdoses in Tennessee from 2019 to 2022. Deaths were linked to Controlled Substances Monitoring Program data deterministically using name and date of birth. Nonmedical use was defined as a decedent having a prescription substance on toxicology but not having an active prescription for that substance at the time of death. Descriptive statistics were performed to assess prevalence overall and examine differences between drug classes.
Results: We identified 7,281 SUDORS deaths from January 2019-2022 with complete toxicology that were able to be linked to prescription data. The median age of decedents was 40 years with 34.2% female and 65.8% males. Prevalence of nonmedical use differed for each category, 1,263(17.3%) for nonmedical opioid use, 1,216(16.7%) for nonmedical benzodiazepine use, 436 (6.0%) for nonmedical gabapentin use, and 152 (2.1%) for nonmedical stimulant use. Overtime, nonmedical use of opioids, benzodiazepines, and stimulants has decreased.
Conclusion: Through linkage of fatal overdose and prescription data, we found the prevalence of nonmedical use to be 33% in Tennessee. Increasing education on the dangers of nonmedical use, the importance of safe drug disposal, storage, and only using medications as prescribed is encouraged to reduce improper use as the drug landscape continues to shift.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/10826084.2025.2454653 | DOI Listing |
Annu Rev Clin Psychol
January 2025
Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; email:
The opioid crisis, driven by illicitly manufactured fentanyl, presents significant challenges in treating opioid use disorder (OUD) and opioid withdrawal syndrome. Fentanyl is uniquely lethal due to its rapid onset and respiratory depressant effects, driving the surge in overdose deaths. This review examines the limitations of traditional diagnostic criteria like those of the , Fifth Edition, Text Revision (DSM-5-TR) and explores the potential of dimensional models such as the Hierarchical Taxonomy of Psychopathology (HiTOP) for a more nuanced understanding of OUD.
View Article and Find Full Text PDFAIDS
March 2025
Faculty of Health Sciences, Simon Fraser University, Burnaby.
The breadth of the overdose crisis is underestimated because of a lack of quantifying nonfatal overdoses. We estimate the proportion of nonfatal overdoses among all people with HIV (PWH) in British Columbia, Canada, and the prevalence of fatal overdoses among people who had a nonfatal overdose, stratified by sex. A small proportion of PWH who experienced a nonfatal overdose subsequently died of a fatal overdose, signaling opportunities for crucial interventions and treatment to prevent overdose death.
View Article and Find Full Text PDFSubst Use Misuse
January 2025
Tennessee Department of Health, Office of Informatics and Analytics, Nashville, TN, USA.
Background: While illicit substances are commonly involved in the overdose crisis, prescription substances still play a role. Oftentimes, decedents do not have prescriptions for these substances at the time of death. As such, we sought to examine the prevalence of nonmedical drug use in Tennessee through linkage of fatal drug overdose and prescription data.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!